Answers from the Lab Podcast Por Mayo Clinic Laboratories arte de portada

Answers from the Lab

Answers from the Lab

De: Mayo Clinic Laboratories
Escúchala gratis

Acerca de esta escucha

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.© 2022 Mayo Foundation for Medical Education and Research. All rights reserved. Ciencia Enfermedades Físicas Hygiene & Healthy Living
Episodios
  • Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D.
    May 8 2025

    In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss tick-borne diseases. They cover:

    • Different diseases patients can get from ticks.
    • Disease prevention, including Dr. Pritt’s A through Z flash cards with tips for people to protect themselves from infectious insects.
    • Laboratory medicine’s valuable role in testing and educating providers to diagnose patients quickly and accurately.
    • Clinical areas most likely to encounter patients with tick-borne diseases.
    • Reliable sources for details about the prevalence of different diseases around the country (e.g., U.S. Centers for Disease Control and Prevention (CDC) and Mayo Clinic Laboratories).
    Más Menos
    14 m
  • Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.
    Apr 24 2025

    In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion. They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test. They covered:

    • Details about how the cerebrospinal fluid biomarker test (Mayo ID: ASYNC) benefits patients exhibiting signs and symptoms of clinically uncertain cognitive decline or clinically uncertain Parkinsonian syndromes.
    • Groundbreaking science on proteins that Amprion leveraged to create a solution that meaningfully impacts patient care and provides value to clinicians.
    • Information physicians receive from the test, and when they should consider ordering it for their patients.
    • Opportunities to change diagnostic journeys by providing accurate, early diagnosis with SAAmplify–αSYN.


    Más Menos
    22 m
  • Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.
    Apr 15 2025

    Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the patient from the arsenic source to ease symptoms and prevent cancer risk.


    Speaker 3: (00:33)
    Do you mind telling us a little bit about yourself and your background?

    Speaker 3: (01:45)
    Could you please provide us with an overview of arsenic, how people get exposed, and the laboratory testing for arsenic and arsenic speciation?

    Speaker 3: (05:25)
    Which patients should have this testing, and when should it be performed?

    Speaker 3: (06:57)
    What alternative test options are available, and how does testing at Mayo Clinic compare?

    Speaker 3: (08:37)

    How are the results used in patient care?

    Más Menos
    11 m
adbl_web_global_use_to_activate_webcro805_stickypopup
Todavía no hay opiniones